![Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/acsami.1c08290/asset/images/medium/am1c08290_0006.gif)
Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces
Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces
![Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/acsami.1c08290/asset/images/medium/am1c08290_0010.gif)
Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces
![Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/acsami.1c08290/asset/images/medium/am1c08290_0009.gif)